Juliet Sharkey
3 Apr 2026OpenAI $852B, Legora $100M ARR, SpaxeX IPO, April Fools Award
Connect2Me Health Out of Stealth: Brain Tracking and a $2M Raise
Rufus and Juliette announce Connect2Me Health has come out of stealth with a $2m fundraise. Rufus describes the AI/ML platform, which integrates neuroimaging with lifestyle, wearable and contextual data to track how the brain changes over time and mitigate trajectories toward neurological disease. Asked why neurotech lags wearables like Whoop, he points to accessibility, monitoring cadence and actionability — framing brain tracking like a regular eye or blood test — while Juliette outlines use cases in clinics (continuous objective monitoring replacing one-off cognitive tests), elite sports teams, and device/platform partnerships.
Brain Tracking Go-To-Market: Regulation, Clinics and Roadmap
On rolling the product out, the team describes two regulatory buckets — wellness, with no diagnostic claims, GDPR-compliant data practices and CE-marked devices, and clinical — plus quick-to-set-up hardware that can run in clinics or pop-up settings. Go-to-market aims to make brain tracking as habitual as tracking sleep or steps. The next six months center on peer-reviewed metrics from continuous studies with Imperial College London and an inference model, launching with the announcement, that links lifestyle factors to brain metrics.